Abstract
Pancreatic secretory trypsin inhibitor (PSTI), a specific trypsin inhibitor, has been isolated from pancreatic tissue and pancreatic juice1,2,.Increased serum levels of immunoreactive PSTI (irPSTI) have been reported in patients with pancreatic diseases3,4 but also in patients with extrapancreatic carcinomas, inflammatory gastrointestinal diseases and after major abdominal surgery5,6,7,8,9. In patients operated on with total pancreatectomy normal serum levels of irPSTI have been found9. These results indicate an additional extrapancreatic source of PSTI. The aim of the present study was to analyse different types of gastrointestinal mucosa for the content and localization of irPSTI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kazal, L.A., Spicer, D.S., and Brahinsky, R.A., Isolation of a crystalline trypsine inhibitor-anticoagulant protein from pancreas. J.Am.Chem.Soc.70: 3034–3040 (1948).
Eddeland, A., Ohlsson, K., Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor. Scand.J.Clin. Lab. Invest. 38: 261–267 (1978).
Eddeland, A., Ohlsson, K., A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids. Hoppe-Seyler’s Z. Physiol. Chem. 359: 671–675 (1978).
Otsuki, M., Oka, T., Suehiro, I., Okabayashi, Y., Ohki, A., Yuu, H., and Baba, S., Serum pancreatic secretory trypsin inhibitor in pancreatic disease. Clin. Chim. Acta 142: 231–240 (1984).
Huhtala, M.-L., Kahanpää, K., Seppälä, M., Halila, H., Stenman, U.-H., Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy. Int. J. Cancer 31: 711–714 (1983).
Murata, A., Ogawa, M., Matsuda, K., Matsuura, N., Kosaki, G., Inoue, M., Ueda, G., Kurachi, K., Immunoreactive pancreatic secretory trypson inhibitor in gynecological diseases. Res. Commun. Chem. Path. Pharm. 41: 493–499 (1983).
Matsuda, K., Ogawa, M., Murata, A., Kitahara, 0., Kosaki, G., Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res. Commun. Chem. Path. Pharm. 40: 301–305 (1983).
Lasson, Å., Borgström, A., Ohlsson, K., Elevated PSTI-levels during severe inflammatory disease, renal insufficiency and after various surgical procedures. Scand.J.Gastroenterol. 21: 1275–1280 (1986).
Matsuda, K., Ogawa, M., Shibata, T., Nishibe, S., Miyauchi, K., Matsuda, Y., Mori, T., Postoperative elevation of serum pancreatic secretory trypsin inhibitor. Am. J. Gastroenterol. 80: 694–698 (1985).
Sternberger, L.A., Hardy Jr., P.H., Cuculis, J.J., Meyer, H.G., The unlabelled antibody enzyme method of immunochemistry. Preparations and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J. Histochem. Cytochem. 18: 315–333 (1970).
Claeson, G., Aurell, L., Karlsson, G., Gustavsson., S., Friberger., P., Arielly., S., Simonssen., R. In: Scully, MF., Kakkar, VV. (eds.), Chromogenic Peptide Substrates, Churchill Livingstone, London, pp. 20–31 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this paper
Cite this paper
Bohe, M., Lindström, C., Ohlsson, K. (1988). Immunoreactive Pancreatic Secretory Trypsin Inhibitor in Gastrointestinal Mucosa. In: Hörl, W.H., Heidland, A. (eds) Proteases II. Advances in Experimental Medicine and Biology, vol 240. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1057-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1057-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8313-3
Online ISBN: 978-1-4613-1057-0
eBook Packages: Springer Book Archive